Mapping and characterization of iron compounds in Alzheimer's tissue

Journal of Alzheimer's Disease

Volumn 10, Issue 2-3, 2006, Pages 215-222

  Collingwood, Joanna ^a   Dobson, Jon ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Electron microscopy; Ferritin; Hemosiderin; Iron; Magnetite; Magnetometry; Synchrotron; X ray

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; IRON DERIVATIVE; MAGNETITE;

ALZHEIMER DISEASE; BRAIN TISSUE; DEGENERATIVE DISEASE; EARLY DIAGNOSIS; ELECTRON MICROSCOPY; HUMAN; IRON STORAGE; METAL EXTRACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNCHROTRON; TISSUE SECTION; X RAY FLUORESCENCE;

EID: 33751098772     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-102-308     Document Type: Review

References (64)

1. S.C. Andrews, A. Treffry and P.M. Harrison, Siderosomal ferritin. The missing link between ferritin and haemosiderin? Biochem. J. 245 (1987), 439-446.
2. G. Bartzokis and T.A. Tishler, MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease, Cell. Molec. Biol. 46 (2000), 821-834.
3. G. Bartzokis, T.A. Tishler, I.S. Shin, P.H. Lu and J.L. Cummings, Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases, Ann. NY Acad Sci. 1012 (2004), 224-236.
4. G. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood and M.A. Smith, Iron: a pathological mediator of Alzheimer disease, Dev. Neurosci. 24 (2002), 184-187.
5. B. Brocklehurst, Spin correlation in the geminate recombination of radical ions in hydrocarbons, J. Chem Soc. Faraday Trans. II 72 (1976), 1869-1884.
6. J.R. Burdo and J.R. Conner, Brain iron uptake and homeostatic mechanisms: an overview, Biometals 16 (2003), 63-75.
7. G. Casadesus, M.A. Smith, X. Zhu, G. Aliev, A.D. Cash, K. Honda, R.B. Petersen and G. Perry, Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species, J. Alzh. Dis. 6 (2004), 165-169.
8. J.F. Collingwood, A. Mikhaylova, M.R. Davidson, C. Batich, W.J. Streit, T. Eskin, J. Terry, R. Barrea and J. Dobson, High-Resolution X-ray Absorption Spectroscopy Studies of Metal Compounds in Neurodegenerative Brain Tissue, APS Activity Report, 2004.
9. J.F. Collingwood, A. Mikhaylova, M. Davidson, C. Batich, W.J. Streit, J. Terry and J. Dobson, In situ Characterization and Mapping of Iron Compounds in Alzheimer's Tissue, J. Alzh. Dis. 7 (2005), 267-272.
10. J.F. Collingwood, A. Mikhaylova, M.R. Davidson, C. Batich, W.J. Streit, T. Eskin, J. Terry, R. Barrea, R.S. Underhill and J. Dobson, High-resolution x-ray absorption spectroscopy studies of metal compounds in neurodegenerative brain tissue, J. Phys. Conf. Ser. 17 (2005), 54-60.
11. J.M. Cowley, D.E. Janney, R.C. Gerkin and P.R. Buseck, The structure of ferritin cores determined by electron nanodiffraction J. Struct. Biol. 13 (2000), 210-216.
12. J. Dobson and P. Grassi, Magnetic properties of human hippocampal tissue: Evaluation of artefact and contamination sources, Brain Res. Bull. 39 (1996), 255-259.
13. J. Dobson, Nanoscale biogenic iron oxides and neurodegenerative disease, FEBS Lett. 496 (2001), 1-5.
14. J. Dobson, On the structural form of iron in ferritin cores associated with Progressive Supranuclear Palsy and Alzheimer's disease, Cell. Mol. Biol. OL47 (2001), 49-50.
15. J. Dobson, Magnetic iron compounds in neurological disorders, Ann. NY Acad. Sci. 1012 (2004), 183-192.
16. J. Dobson and C. Batich, A Potential Iron-Based Mechanism for Enhanced Deposition of Amyoid Plaques Due to Cognitive Stimulation in Alzheimer's Disease, J. Neuropath. & Exper. Neurol. 63 (2004), 674-675.
17. B. Drayer, P. Burger, R. Darwin, S. Riederer, R. Herfkens and G.A. Johnson, MRI of Brain Iron, AJR Am J Roentgenol. 147 (1986), 103-110.
18. J.R. Dunn, M. Fuller, J. Zoeger, J. Dobson, F. Heller, E. Caine and B.M. Moskowitz, Magnetic material in the human hippocampus, Brain Res. Bull. 36 (1995), 149-153.
19. E. Floor, Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease, Cell. Molec. Biol. 46 (2000), 709-720.
20. G.C. Ford, P.M. Harrison, D.W. Rice, J.M. Smith, A. Treffry, J.L. White and J. Yariv, Ferritin: design and formation of an iron-storage molecule, Philos. Trans. R. Soc. Lond. B Biol. Sci. 304 (1984), 551-565.
21. C.D. Garner, R.J. Ward and T.J. Peters, Iron K-edge absorption spectroscopic investigation of the cores of ferritin and haemosiderins, Biochim. Biophys. Acta 1115 (1991), 145-150.
22. L. Goodman, Alzheimer's disease - a clinicopathologic analysis of 23 cases with a theory on pathogenesis, J. Nerv. Ment. Dis. 118 (1953), 97-130.
23. Y. Gossuin, D. Hautot, R. Muller, Q. Pankhurst, J. Dobson, C. Morris, P. Gillis and J. Collingwood, Looking for biogenic magnetite in brain ferritin using NMR relaxometry, NMR Biomed (2005) 8 (2005), 469-472.
24. P.D. Griffiths, B.R. Dobson, G.R. Jones and D.T. Clarke, Iron in the basal ganglia in Parkinson's disease - An in vitro study using extended X-ray absorption fine structure and cryoelectron microscopy, Brain 122 (1999), 667-673.
25. E.M. Haacke, N.Y. Cheng, M.J. House, Q. Liu, J. Neelavalli, R.J. Ogg, A. Khan, M. Ayaz, W. Kirsch and A. Obenaus, Imaging iron stores in the brain using magnetic resonance imaging, Magn Reson Imaging 23 (2005), 1-25.
26. P.M. Harrison and P. Arosio, The ferritins: molecular properties, iron storage function and cellular regulation, Biochim Biophys Acta 1275 (1996), 161-203.
27. D. Hautot, Q.A. Pankhurst, N. Khan and J. Dobson, Preliminary evaluation of nanoscale biogenic magnetite and Alzheimer's disease, Proc. Royal Soc. Lon. B: Biol. Lett. 270 (2003), S62-S64.
28. D. Hautot, Q.A. Pankhurst and J. Dobson, Superconducting quantum interference device measurements of dilute magnetic materials in biological samples, Rev. Sci. Instrum. 76 (2005), 045101.
29. S.M. Heald, E.A. Stern, B. Bunker, E.M. Holt and S.L. Holt, Structure of the iron-containing core in ferritin by the extended X-ray absorption fine structure technique. J. Am. Chem. Soc. 101 (1979), 67-73.
30. K. Honda, G. Casadesus, R. Petersen, G. Perry and M.A. Smith, Oxidative stress and redox-active iron in Alzheimer's disease, Ann. NY Acad. Sci. 1012 (2004), 179-182.
31. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon and C. Exley, Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J. Alzh. Dis. 6 (2004), 291-301.
32. A. Ide-Ektessabi, T. Kawakami and F. Watt, Distribution and chemical state analysis of iron in the Parkinsonian substantia nigra using synchrotron radiation micro beams, Nucl. Instr. and Meth. in Phys. Res. B 213 (2004), 590-594.
33. Y. Ke and Z. Qian, Iron misregulation in the brain: a primary cause of neurodegenerative disorders, The Lancet Neurol 2 (2003), 246-253.
34. A. Khan, J. Dobson and C. Exley, The redox cycling of Fe(II) by Aβ42, Free Rad. Biol. Med. (2005), in press.
35. J.L. Kirschvink, A. Kobayashi-Kirschvink and B.J. Woodford, Magnetite biomineralization in the human brain, Proc. Natl. Acad. Sci. USA 89 (1992), 7683-7687.
36. S. Mann, The study of biominerals by high resolution transmission electron microscopy, Scan Electron Microsc. 2 (1986), 393-413.
37. W.R. Markesbery, Oxidative stress hypothesis in Alzheimer's disease. Free Rad. Biol. Med. 23 (1997), 134-147.
38. A. Mikhailova, M. Davidson, Y. Guyodo, H. Tostmann, J. Culp, J. Dobson, R. Duran, J. Channell and C. Batich, Mapping and Characterization of Iron-Containing Particles in Brain Tissue, APS Activity Report (2000), http://www.aps.anl.gov/apsar2000/mikhailovaa1.pdf.
39. A. Mikhaylova, M. Davidson, J.E.T. Channel, Y. Guyodo, C. Batich and J. Dobson, Detection, identification and mapping of iron anomalies in brain tissue using x-ray absorption spectroscopy, J. Royal Soc. Interface 2 (2005), 33-37.
40. C.M. Morris, J.M. Candy, A.E. Oakley, C.A. Bloxham and J.A. Edwardson, Histochemical distribution of non-haem iron in the human brain, Acta. Anat. (Basel) 144 (1992), 235-257.
41. M. Newville, P. Livins, Y. Yacoby, E.A. Stern and J.J. Rehr, Near-edge x-ray-absorption fine structure of Pb: A comparison of theory and experiment, Phys. Rev. B. 47 (1993), 14126-14131.
42. H. Pardoe, W. Chua-anusorn, T.G. St. Pierre and J. Dobson, Detection limits for ferromagnetic particle concentrations using magnetic resonance imaging-based proton transverse relaxation rate measurements, Phys. & Med. Biol. 48 (2003), 89-95.
43. P.P. Perl and P.F. Good, Comparative techniques for determination of cellular iron distribution in brain tissue, Ann. Neurol. 32 (1992), S76-S81.
44. M. Perez, J.M. Valpuesta, E.M. de Garcini, C. Quintana, M. Arrasate, J.L. Lopez Carrascosa, A. Rabano, J. Garcia de Yebenes and J. Avila, Ferritin is associated with aberrant tau filaments present in progressive supranuclear palsy, Am. J. Path. 152 (1998), 1531-1539.
45. C. Quintana, M. Lancin, C. Marhic, M. P'erez, J. Avila and J.L. Carrascosa, Preliminary high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brain in patients with neurodegenerative PSP and Alzheimer diseases, Cell. & Molec. Biol. 46 (2000), 807-820.
46. C. Quintana, J.M. Cowley and C. Marhic, Electron diffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin, J Struct Biol 147 (2004), 166-178.
47. J.S. Rohrer, Q.T. Islam, G.D. Watt, D.E. Sayers and E.C. Theil, Iron environment in ferritin with large amounts of phosphate, from Azotobacter vinelandii and horse spleen, analyzed using extended x-ray absorption fine structure (EXAFS), Biochemistry 29 (1990), 259-264.
48. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, C.S. Atwood, M. Chevion, G. Perry and M.A. Smith, Redox-active iron mediates amyloid-β toxicity, Free Radic. Biol. Med. 30 (2001), 447-450.
49. M.A. Smith, P.L.R. Harris, L.M. Sayre and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc. Natl. Acad. Sci. USA 94 (1997), 9866-9868.
50. L.M. Sayre, G. Perry, P.L.R. Harris, Y.H. Liu, K.H. Schubert and M.A. Smith, In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals, J. Neurochem 74 (2000), 270-279.
51. P.P. Schultheiss-Grassi, R. Wessiken and J. Dobson, TEM observation of biogenic magnetite extracted from the human hippocampus, Biochim. Biophys. Acta 1426 (1999), 212-216.
52. J.F. Schenck and E.A. Zimmerman, High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed. 17 (2004), 433-445.
53. D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem. Biophys. Res. Comm. 216 (1995), 702-707.
54. S. Shoham and M.B.H. Youdim, Iron involvement in neuronal damage and microgliosis in models of neurodegenerative disease, Cell. Molec. Biol. 46 (2000), 743-750.
55. T.G. St. Pierre, P. Chan, K.R. Bauchspiess, J. Webb, S. Betteridge, S. Walton and D.P.E. Dickson, Synthesis, structure and magnetic properties of ferritin cores with varying composition and degrees of structural order: models for iron oxide deposits in iron-overload diseases, Coord. Chem. Rev. 151 (1996), 125-143.
56. T.G. St. Pierre, P.R. Clark, W. Chua-anusorn, A. Fleming, H. Pardoe, G.P. Jeffrey, J.K. Olynyk, P. Pootrakul, S. Jones and P. Moroz, Non-invasive measurement and imaging of tissue iron oxide nanoparticle concentrations in vivo using proton relaxometry, J. Phys. Conf. Ser. 17 (2005), 122-126.
57. M. Szczerbowska-Boruchowska, M. Lankosz, J. Ostachowicz, D. Adamek, A. Krygowska-Wajs, B. Tomik, A. Szczudlik, A. Simionovici and S. Bohic, Application of synchrotron radiation for elemental microanalysis of human central nervous system tissue, J. Phys. IV France 2 (2003), 325.
58. U. Till, C.R. Timmel, B. Brocklehurst and P.J. Hore, The influence of very small magnetic fields on radical recombination reactions in the limit of slow recombination, Chem. Phys. Lett. 298 (1998), 7-14.
59. C.R. Timmel, U. Till, B. Brocklehurst, K.A. McLauchlan and P.J. Hore, Effects of weak magnetic fields on free radical recombination reactions, Molec. Phys. 95 (1998), 71-89.
60. F. Watt, Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review, Cell Mol. Biol. (Noisy-legrand) 42 (1996), 17-26.
61. M. Wilke, F. Farges, P. Petit, G.E. Brown and F. Martin, Oxidation state and coordination of Fe in minerals: AnFeK-XANES spectroscopic study, American Mineralogist 86 (2001), 714-730.
62. S. Yoshida, A. Ektessabi and S. Fujisawa, XANES spectroscopy of a single neuron from a patient with Parkinson's disease, J. Synchrotron Rad 8 (2001), 998-1000.
63. L. Zecca, M.B. Youdim, P. Riederer, J.R. Connor and R.R. Crichton, Iron, brain ageing and neurodegenerative disorders, Nat. Rev. Neurosci. 5 (2004), 863-873.
64. G. Zhao, F. Bou-Abdallah, P. Arosio, S. Levi, C. Janus-Chandler and N.D. Chasteen, Multiple pathways for mineral core formation in mamallian apoferritin: The role of hydrogen peroxide, Biochem. 42 (2003), 3142-3150.